dr. Erik jan Dubbink

Medicine & Life Sciences

1. High-Throughput Nucleotide Sequencing 100%
2. Glioma 73%
3. Mutation 72%
4. DNA Methylation 70%
5. Astrocytoma 68%
6. Neoplasms 64%
7. Melanoma 59%
8. Persistent Fetal Circulation Syndrome 53%
9. Circulating Tumor DNA 51%
10. Hereditary Nonpolyposis Colorectal Neoplasms 47%
11. Large Cell Carcinoma 47%
12. Neuroendocrine Carcinoma 46%
13. Gynecologic Surgical Procedures 44%
14. Telomerase 40%
15. Urinary Tract 35%
16. Gene Frequency 35%
17. Tumor Burden 34%
18. Protein-Tyrosine Kinases 32%
19. osimertinib 32%
20. Genome 30%
21. Molecular Biology 29%
22. Survival 28%
23. Urinary Bladder 28%
24. Adenocarcinoma 28%
25. Cell-Free Nucleic Acids 27%
26. Carcinoma 25%
27. Magnetic Resonance Imaging 23%
28. Databases 21%
29. Lung 21%
30. DNA 20%
31. In Situ Hybridization 18%
32. Genes 18%
33. RNA 17%
34. Neoplasm Metastasis 17%
35. Endometrial Neoplasms 16%
36. Recurrence 15%
37. Epithelioid Cells 15%
38. Guidelines 13%
39. Immunohistochemistry 12%
40. Temozolomide 12%
41. Nephroureterectomy 12%
42. Mitosis 11%
43. Molecular Pathology 11%
44. Ovarian Neoplasms 10%
45. Netherlands 9%
46. Nucleic Acid Regulatory Sequences 9%
47. Epigenomics 8%
48. Polymerase Chain Reaction 8%
49. Conjunctival Diseases 7%
50. Psychological Stress 7%